Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Emerging Novel Biologic Agents for Inflammatory Joint Diseases -- Role in Clinical Practice: An Expe
Link ID 11485
Title Emerging Novel Biologic Agents for Inflammatory Joint Diseases -- Role in Clinical Practice: An Expe
Url http://www.medscape.com/viewarticle/584250?src=rss
Description Philip J. Mease, MD, Chief of Rheumatology Research and Clinical Professor of Medicine, University of Washington, Seattle, discusses recent advances with anti-TNF agents for RA.
Medscape Rheumatology
Category Articles > Rheumatology
Keywords
Date Dec 12, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Rheumatology
1. For Smokers With Rheumatoid Arthritis, One More Reason to Quit
  Nonsmokers with early rheumatoid arthritis are more likely than smokers to respond well to methotrexate and biological drugs, researchers from Sweden say. Reuters Health Information
Category:   Articles > Rheumatology


2. The Role of Synovitis in Osteoarthritis
  Increasingly, attention has turned to the role of the synovium in OA as a possible target for pain relief. Therapeutic Advances in Musculoskeletal Disease
Category:   Articles > Rheumatology


3. Infliximab Stops Bone Loss at Hip, but Not Spine or Hand, in Early Rheumatoid Arthritis
  In patients with active early rheumatoid arthritis (RA), adding infliximab to methotrexate can arrest bone loss at the hip, but not at the spine or hand, researchers report in the Annals of the Rheumatic Diseases for December. Reuters Health Information
Category:   Articles > Rheumatology


4. Abatacept Shows Ongoing Benefit in Arthritis Patients
  The results of a 2-year follow-up study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate show the initial benefits of treatment are maintained and might even be enhanced. Reuters Health Information
Category:   Articles > Rheumatology


5. FDA Panel Says No to Sodium Oxybate for Fibromyalgia
  A joint FDA advisory committee has voted against approval of sodium oxybate for fibromyalgia. Medscape Medical News
Category:   Articles > Rheumatology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS